COMPOSITIONS PHARMACEUTIQUES SYNERGIQUES COMPRENANT UNE COMBINAISON D'UN INHIBITEUR DE L'ENZYME 5 alpha-RÉDUCTASE ET D'UN ANTAGONISTE DES RÉCEPTEURS 1 alpha- ADRÉNERGIQUES
REPRESENTACIONES E INVESTIGACIONES MEDICAS S.A. DE C.V.
发明人:
申请号：
EP08712560.5
公开号：
EP2156836B1
申请日:
2008.01.29
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The invention relates to various pharmaceutical compositions consisting of a synergic combination of a 5 ±-reductase enzyme inhibitor agent, such as the active ingredients finasteride or dutasteride, and an ±-adrenergic receptor antagonist agent, such as the active ingredients alfuzosine or doxazosine. Said agents are formulated in a single dosage unit to be orally administered in the form of tablets, and are suitable for treating benign prostatic hyperplasia, and for relieving the symptoms of said illness.
